389 related articles for article (PubMed ID: 25556170)
1. Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms' Tumor 1 Target Genes in Podocyte Differentiation and Maintenance.
Dong L; Pietsch S; Tan Z; Perner B; Sierig R; Kruspe D; Groth M; Witzgall R; Gröne HJ; Platzer M; Englert C
J Am Soc Nephrol; 2015 Sep; 26(9):2118-28. PubMed ID: 25556170
[TBL] [Abstract][Full Text] [Related]
2. Alternatively spliced isoforms of WT1 control podocyte-specific gene expression.
Lefebvre J; Clarkson M; Massa F; Bradford ST; Charlet A; Buske F; Lacas-Gervais S; Schulz H; Gimpel C; Hata Y; Schaefer F; Schedl A
Kidney Int; 2015 Aug; 88(2):321-31. PubMed ID: 25993318
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Analysis of Wilms' Tumor 1-Controlled Gene Expression in Podocytes Reveals Key Regulatory Mechanisms.
Kann M; Ettou S; Jung YL; Lenz MO; Taglienti ME; Park PJ; Schermer B; Benzing T; Kreidberg JA
J Am Soc Nephrol; 2015 Sep; 26(9):2097-104. PubMed ID: 25636411
[TBL] [Abstract][Full Text] [Related]
4. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
Morrison AA; Viney RL; Saleem MA; Ladomery MR
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
[TBL] [Abstract][Full Text] [Related]
5. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
[TBL] [Abstract][Full Text] [Related]
6. WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin.
Palmer RE; Kotsianti A; Cadman B; Boyd T; Gerald W; Haber DA
Curr Biol; 2001 Nov; 11(22):1805-9. PubMed ID: 11719225
[TBL] [Abstract][Full Text] [Related]
7. Activation of podocyte Notch mediates early Wt1 glomerulopathy.
Asfahani RI; Tahoun MM; Miller-Hodges EV; Bellerby J; Virasami AK; Sampson RD; Moulding D; Sebire NJ; Hohenstein P; Scambler PJ; Waters AM
Kidney Int; 2018 Apr; 93(4):903-920. PubMed ID: 29398135
[TBL] [Abstract][Full Text] [Related]
8. Wilms' tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2.
Klattig J; Sierig R; Kruspe D; Besenbeck B; Englert C
Mol Cell Biol; 2007 Jun; 27(12):4355-64. PubMed ID: 17420277
[TBL] [Abstract][Full Text] [Related]
9. TGF-β-activated kinase 1 is crucial in podocyte differentiation and glomerular capillary formation.
Kim SI; Lee SY; Wang Z; Ding Y; Haque N; Zhang J; Zhou J; Choi ME
J Am Soc Nephrol; 2014 Sep; 25(9):1966-78. PubMed ID: 24652804
[TBL] [Abstract][Full Text] [Related]
10. Wt1a, Foxc1a, and the Notch mediator Rbpj physically interact and regulate the formation of podocytes in zebrafish.
O'Brien LL; Grimaldi M; Kostun Z; Wingert RA; Selleck R; Davidson AJ
Dev Biol; 2011 Oct; 358(2):318-30. PubMed ID: 21871448
[TBL] [Abstract][Full Text] [Related]
11. Weighted Gene Correlation Network Analysis (WGCNA) Detected Loss of MAGI2 Promotes Chronic Kidney Disease (CKD) by Podocyte Damage.
Zuo Z; Shen JX; Pan Y; Pu J; Li YG; Shao XH; Wang WP
Cell Physiol Biochem; 2018; 51(1):244-261. PubMed ID: 30448842
[TBL] [Abstract][Full Text] [Related]
12. osr1 is required for podocyte development downstream of wt1a.
Tomar R; Mudumana SP; Pathak N; Hukriede NA; Drummond IA
J Am Soc Nephrol; 2014 Nov; 25(11):2539-45. PubMed ID: 24722440
[TBL] [Abstract][Full Text] [Related]
13. Global polysome analysis of normal and injured podocytes.
Okabe M; Motojima M; Miyazaki Y; Pastan I; Yokoo T; Matsusaka T
Am J Physiol Renal Physiol; 2019 Feb; 316(2):F241-F252. PubMed ID: 30379099
[TBL] [Abstract][Full Text] [Related]
14. Repression of CMIP transcription by WT1 is relevant to podocyte health.
Moktefi A; Zhang SY; Vachin P; Ory V; Henique C; Audard V; Rucker-Martin C; Gouadon E; Eccles M; Schedl A; Heidet L; Ollero M; Sahali D; Pawlak A
Kidney Int; 2016 Dec; 90(6):1298-1311. PubMed ID: 27650733
[TBL] [Abstract][Full Text] [Related]
15. A novel WT1 gene mutation in a three-generation family with progressive isolated focal segmental glomerulosclerosis.
Benetti E; Caridi G; Malaventura C; Dagnino M; Leonardi E; Artifoni L; Ghiggeri GM; Tosatto SC; Murer L
Clin J Am Soc Nephrol; 2010 Apr; 5(4):698-702. PubMed ID: 20150449
[TBL] [Abstract][Full Text] [Related]
16. The Wt1+/R394W mouse displays glomerulosclerosis and early-onset renal failure characteristic of human Denys-Drash syndrome.
Gao F; Maiti S; Sun G; Ordonez NG; Udtha M; Deng JM; Behringer RR; Huff V
Mol Cell Biol; 2004 Nov; 24(22):9899-910. PubMed ID: 15509792
[TBL] [Abstract][Full Text] [Related]
17. The predominant WT1 isoform (+KTS) encodes a DNA-binding protein targeting the planar cell polarity gene Scribble in renal podocytes.
Wells J; Rivera MN; Kim WJ; Starbuck K; Haber DA
Mol Cancer Res; 2010 Jul; 8(7):975-85. PubMed ID: 20571064
[TBL] [Abstract][Full Text] [Related]
18. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes.
Ratelade J; Arrondel C; Hamard G; Garbay S; Harvey S; Biebuyck N; Schulz H; Hastie N; Pontoglio M; Gubler MC; Antignac C; Heidet L
Hum Mol Genet; 2010 Jan; 19(1):1-15. PubMed ID: 19797313
[TBL] [Abstract][Full Text] [Related]
19. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development.
Natoli TA; Liu J; Eremina V; Hodgens K; Li C; Hamano Y; Mundel P; Kalluri R; Miner JH; Quaggin SE; Kreidberg JA
J Am Soc Nephrol; 2002 Aug; 13(8):2058-67. PubMed ID: 12138137
[TBL] [Abstract][Full Text] [Related]
20. WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.
Ramanathan AS; Vijayan M; Rajagopal S; Rajendiran P; Senguttuvan P
Mol Cell Biochem; 2017 Feb; 426(1-2):177-181. PubMed ID: 27885584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
